A multi-centered phase 1 trial to evaluate the memory responses to a single boosting vaccination with ALVAC-HIV vCP205 [HIV vaccine vCP205] in volunteers who have previously received poxvirus-based vaccines
Phase of Trial: Phase I
Latest Information Update: 28 Sep 2008
At a glance
- Drugs HIV vaccine vCP205 (Primary)
- Indications HIV infections
- Focus Pharmacodynamics; Registrational
- 28 Sep 2008 Actual initiation date added as 1 Mar 2000 as reported by ClinicalTrials.gov.
- 28 Sep 2008 Actual end date changed added as 1 May 2001 as reported by ClinicalTrials.gov.
- 28 Sep 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.